LYTIR

Insider · SEC Form 4 · Director

Christoph Samuel Ziegler

Filed with the SEC as Ziegler Christoph Samuel; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: bought $33K of VRXA. Filed 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

  1. VRXABought: Veraxa Biotech AG - Post de-SPAC Oct 20, 2026 30,000 shares filed Oct 21, 2026 37,932 shares held directly after, as filed filing $33K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.